If results are promising, the programme moves to Phase 3: larger, global, randomised trials involving, dependent on the indication hundreds to sometimes even thousands of participants, designed to confirm efficacy and build a robust safety profile
For researchers who prefer to work with each compound separately, Durham Peptides also stocks the individual peptides BPC-157 (10mg) and TB-500 (10mg)
BPC-157 research focuses heavily on musculoskeletal soft tissue, with multiple studies examining tendon, ligament, and muscle healing
For longer cycles, the higher dose weeks dominate
Research-use-only labeling and an age check on the product page
Schedule an appointment online or call us at 919-781-5600 to be seenoften within 48 hours